tiprankstipranks
Madrigal (MDGL)
NASDAQ:MDGL
US Market
MDGL
Madrigal Pharmaceuticals
RESEARCH TOOLSreports
Want to see MDGL full AI Analyst Report?

Madrigal Pharmaceuticals (MDGL) Income Statement

1,344 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q1 2026), Madrigal Pharmaceuticals's total revenue was $311.34M, an increase of 126.84% from the same quarter last year. In Q1, Madrigal Pharmaceuticals's net income was $-94.39M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 958.40M$ 180.13M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 902.25M$ 173.90M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.20B$ 671.77M$ 380.50M$ 293.57M$ 242.48M
Depreciation and Amortization
$ 1.51M$ 1.10M$ 527.00K$ 467.00K$ 405.00K
EBITDA
$ -264.47M$ -450.13M$ -360.39M$ -290.92M$ -241.44M
Operating Income
$ -300.10M$ -497.88M$ -380.50M$ -293.57M$ -242.48M
Other Income/Expenses
$ 11.81M$ 31.98M$ 6.87M$ -1.78M$ 636.00K
Pretax Income
$ -288.28M$ -465.89M$ -373.63M$ -295.35M$ -241.85M
Net Income
$ -288.28M$ -465.89M$ -373.63M$ -295.35M$ -241.85M
Per Share Metrics
Basic EPS
$ -12.85$ -21.90$ -19.99$ -17.23$ -14.63
Diluted EPS
$ -12.85$ -21.90$ -19.99$ -17.23$ -14.63
Weighted Average Shares Outstanding
 22.43M 21.27M 18.69M 17.14M 16.54M
Weighted Average Shares Outstanding (Diluted)
 22.43M 21.27M 18.69M 17.14M 16.54M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History